M. Kosch

Type de document

Co-auteur

W. Wick

A. Wick

A. Weyerbrock

M. Weller

S. Villa

M.J. van den Bent

M. J. Taphoorn

R. Stupp

J. Steuve

P. Roth

D. Ricard

M. Platten

G. Pesce

C. Marosi

B. Lhermitte

K. Hopkins

K. Homicsko

M.E. Hegi

M.F. Hamou

T. Gorlia

V. Golfinopoulos

J.S. Frenel

M. Campone

A. A. Brandes

P. Bady

Date

Source

Serveur académique Lausannois (1)

Mot-clé

tissu (corporel) (1) thérapie (1) norme (1) protocole (1) danger (1) dosage (1) ADN (1) âge (1) adulte (1) cancer (1) jeune (1) survie (1) Testing (1) Treatment (1) Cancer (1) Derivatives (1) Ci (Chinese poetry) (1) Therapeutics (1) Testing (1) Survival (1) Radiotherapy (1) Population (1) Phosphorylation (1) Performance (1) Patients (1) Adjustable rate mortgages (1) Months (1) Methylation (1) Manufacturers' agents (1) Human beings (1)

Documents écrit par M. Kosch (1) | parle de M. Kosch (0)

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).

W. Wick et al. (1 oct. 2016)